Skip to main content
NCBI home page
Springer logoLink to Springer
. 2022 Dec 2;23(1):52–53. doi: 10.1007/s12311-022-01501-5

Correction to: Clinical trial-ready patient cohorts for multiple system atrophy: coupling biospecimen and iPSC banking to longitudinal deep-phenotyping

Alain Ndayisaba 1,2, Ariana T Pitaro 1, Ashlan S Willett 1, Kristie A Jones 1, Claudio Melo de Gusmao 1, Abby L Olsen 1, Jisoo Kim 3, Eero Rissanen 1, Jared K Woods 4, Sharan R Srinivasan 1,5, Anna Nagy 1, Amanda Nagy 1, Merlyne Mesidor 1, Steven Cicero 1, Viharkumar Patel 4, Derek H Oakley 6, Idil Tuncali 1, Katherine Taglieri-Noble 1, Emily C Clark 1, Jordan Paulson 1, Richard C Krolewski 1, Gary P Ho 1, Albert Y Hung 1,7, Anne-Marie Wills 7, Michael T Hayes 1, Jason P Macmore 7, Luigi Warren 8, Pamela G Bower 9, Carol B Langer 9, Lawrence R Kellerman 9, Christopher W Humphreys 10, Bonnie I Glanz 1, Elodi J Dielubanza 11, Matthew P Frosch 6, Roy L Freeman 12, Christopher H Gibbons 12, Nadia Stefanova 2, Tanuja Chitnis 1, Howard L Weiner 1, Clemens R Scherzer 1, Sonja W Scholz 13,14, Dana Vuzman 15,16, Laura M Cox 1, Gregor Wenning 2, Jeremy D Schmahmann 7, Anoopum S Gupta 7, Peter Novak 1, Geoffrey S Young 3, Mel B Feany 4, Tarun Singhal 1, Vikram Khurana 1,✉
PMCID: PMC10864413  PMID: 36456723

Correction to: The Cerebellum

https://doi.org/10.1007/s12311-022-01471-8

In the course of preparation of the document, an author with a critical contribution, Dr. Anoopum Gupta, was dropped from the author list inadvertently due to a clerical error.

Dr. Gupta contributed the Neurobooth methodology to this work. We have now amended the author list and also the Funding section as presented below.

Funding

A. N. was supported by a Max Kade Fellowship. S. S. was supported by grants from the Parkinson’s Foundation and National Ataxia Foundation. C. G. is supported by a Sudarsky Scholarship from the Division of Movement Disorders at Brigham and Women’s Hospital. Essential grant funding was provided by the Brigham and Women’s Hospital Research Institute (BRI) Director’s Transformative Award, the Barbara Bloom Ranson Fund for Biomarker Discovery in MSA, and NIH grants 1P30AG062421-01 and 1R01NS109209-01A1 (A. T. P., A. S. W., V. K.). V. K. is a New York Stem Cell Foundation Robertson Investigator, a George Cotzias Fellow of the American Parkinson’s Disease Association (APDA), recipient of the 2018 Bishop Dr. Karl Golser Award, and a co-founder of Yumanity Therapeutics and DaCapo Brainscience. T. S. reports receiving research grants from Sanofi-Genzyme and Novartis Pharmaceuticals and research funding from the US Government Department of Defense, National Multiple Sclerosis Society, Nancy Davis Foundation’s “Race to Erase MS” program, Harvard Neuro-Discovery Center, Ann Romney Center for Neurologic Diseases, and Water Cove Charitable Foundation. E. R. reports receiving a research fellowship grant from Sigrid Jusélius Foundation. S. W. S. was supported in part by NIH grant 1ZIANS003154. A. S. G. was supported by Massachusetts Life Sciences Center, R01NS117826, and Biogen Inc. to create and install Neurobooth at Massachusetts General Hospital. D. V. serves as founder of Talerics Consulting, LLC. L. R. K., C. B. L., P. G. B., and V. K. are members of the Board of Directors of the Multiple System Atrophy Coalition. The remaining authors did not receive support from any organization for the submitted work.

Data availability

None.

Footnotes

Alain Ndayisaba, Ariana T. Pitaro and Ashlan S. Willett are co-first authors.

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

None.

Articles from Cerebellum (London, England) are provided here courtesy of Springer

RESOURCES